Yenidoğan sepsisi ve bebek ölümleri

Sepsis yenidoğan bebeklerde önemli bir mortalite ve morbidite nedenidir. Yenidoğan sepsisi erken başlangıçlı, geç başlangıçlı ve çok geç başlangıçlı sepsis olarak üçe ayrılmaktadır. Erken sepsis için başlıca risk faktörleri prematürite, düşük doğum ağırlığı, erken membran rüptürü, korioamnionit ve annenin doğum kanalının B grubu streptokoklar ile kolonizasyonudur. Geç başlangıçlı ve çok geç başlangıçlı sepsis sıklıkla hastane kaynaklıdır. Optimal tanı ve tedavi stratejilerini tanımlamak zordur, çünkü yenidoğan sepsisinin semptomları ve bulguları özgün değildir. Bebek ölümlerinin yaklaşık üçte ikisi yaşamın ilk bir ayında görülmektedir. Bu ölümlerin % 50-75’ine infeksiyon ve prematürite komplikasyonlarının neden olduğu tahmin edilmektedir. Bu makalede, yenidoğan sepsisinin klinik bulguları, tanısı, tedavisi ve bebek ölümleri gözden geçirilmiştir.

Neonatal sepsis and infant mortality

Sepsis is a significant cause of morbidity and mortality in the newborn infants. Neonatal sepsis divided into three categories, namely early-onset sepsis, late-onset sepsis and very late-onset sepsis. Primary risk factors for early-onset sepsis include prematurity, low birth weight, prolonged rupture of membranes, chorioamnionitis, and maternal colonization with group B Streptococcus. Late-onset sepsis and very late-onset sepsis are frequently nosocomial. Optimal diagnosis and treatment strategies are difficult to define, because the signs and symptoms of neonatal sepsis are nonspecific. Appoximately twothirds of global infant mortality occur in the first month of life. Infections and complications of prematurity cause an estimated 50-75 % of these death. In this article, the diagnosis, treatment and clinical findings of neonatal sepsis, and infant mortality are reviewed.

Kaynakça

1. Arnon S, Litmanovitz I, Regev RH, Bauer S, Shainkin-Kestenbaum R, Dolfin T: Serum amyloid A:an early and accurate marker of neonatal earlyonset sepsis, J Perinatol 2007;27(5):297-302.

2. Baltimore RS: Perinatal bacterial and fungal infections,“Jenson HB, Baltimore RS (eds): Pediatric Infectious Diseases, 2. baskı” kitabında s.1119-34,WB Saunders Company, Philadelphia (2002).

3. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG: Seventy-five years neonatal sepsis at Yale: 1928-2003, Pediatrics 2005;116(3):595-602.

4. Chavez-Bueno S, McCracken GH Jr: Bacterial meningitis in children, Pediatr Clin North Am 2005;52(3):795-810.

5. Chiesa C, Panero A, Osborn JF, Simonetti AF, Pacifico L: Diagnosis of neonatal sepsis: a clinical and laboratory challenge, Clin Chem 2004;50(2):279-87.

6. Chiesa C, Pellegrini G, Panero A et al: C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection, Clin Chem 2003;49(1):60-8.

7. Darmstadt GL, Lawn JE, Costello A: Advancing the state of the world’s newborns, Bull World Health Organ 2003;81(3):224-5..

8. Doellner H, Arntzen KJ, Haereid PE, Aag S, Austgulen R: Interleukin-6 concentrations in neonates evaluated for sepsis, J Pediatr 1998;132(2):295-9.

9. Edwards MS, Baker CJ: Sepsis in the newborn,“Gershon AA, Hotez PJ, Katz SL (eds): Krugman’s Infectious Diseases of Children, 11. baskı”kitabında s.545-61, Mosby Co., St Louis (2004).

10. Gerdes JS: Diagnosis and management of bacterial infections in the neonate, Pediatr Clin North Am 2004;51(4):939-59.

11. Gordon A, Isaacs D: Late-onset infection and the role of antibiotic prescribing policies, Curr Opin Infect Dis 2004;17(3):231-6.

12. Gray JW: Surveillance of infection in neonatal intensive care units, Early Hum Dev 2007;83(3):157-63.

13. Haque KN: Definitions of bloodstream infection in the newborn, Pediatr Crit Care Med 2005;6(3 Suppl): S45-9.

14. Heron MP, Smith BL: Deaths: leading causes for 2003, Natl Vital Stat Rep 2007;55(10):1-92.

15. Hyde TB, Hilger TM, Reingold A et al: Trends in incidence and antimicrobial resistance of early-onset sepsis: population based surveillance in San Francisco and Atlanta, Pediatrics 2002;110(4):690-5.

16. Keven MC: Son trimester gebelerde, rektovajinal florada grup B streptokok taşıyıcılığı sıklığı ve antibiotik duyarlılığının araştırılması, Uzmanlık Tezi, Sağlık Bakanlığı Bakırköy Doğumevi, Kadın ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi,istanbul (2005).

17. Lebel M, Tapiero B: Bacteremia, sepsis and septic shock, “Jenson HB, Baltimore RS (eds): Pediatric Infectious Diseases, 2.baskı’’ kitabında s.279-95,7. Darmstadt GL, Lawn JE, Costello A: Advancing the state of the world’s newborns, Bull World Health Organ 2003;81(3):224-5.

18. Ohlsson A, Lacy JB: Intravenous immunoglobulin for preventing infection in preterm and/or lowbirth-weight infants, Cochrane Database Syst Rev 2004;1:CD000361.

19. Osrin D, Vergnano S, Costello A: Serious bacterial infections in newborn infants in developing countries, Curr Opin Infect Dis 2004;17(3):217-24.

20. Parker MM, Hazelzet JA, Carcillo JA: Pediatric considerations, Crit Care Med 2004;32(11 Suppl):S591-4.

21. Platt JS, O’Brien WF: Group B Streptococcus: prevention of early-onset neonatal sepsis, Obstet Gynocol Surv 2003;58(3):191-6.

22. Saez-Llorens X, McCracken GH: Perinatal bacterial diseases, “Feigin RD, Cherry JD, Demmler GJ et al (eds): Text Book of Pediatric Infectious Diseases, 5. baskı” kitabında s.929-66, WB Saunders Company, Philadelphia (2004).

23. Silveira RC, Procianoy RS: Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin- 1-beta for early diagnosis of neonatal sepsis, Acta Paediatr 1999;88(6):647-50.

24. Stoll BJ: Infections of the neonatal infant, “Behrman RE, Kliegman RM, Jenson HB (eds): Nelson Text Book of Pediatrics, 17. baskı” kitabında s.623-40, WB Saunders Company, Philadelphia (2004).

25. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Schimmel MS: The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants, Acta Paediatr 2006;95(12):1571-6.

26. Weisman LE: Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient, Curr Opin Infect Dis 2004;17(3):237-41.

27. World Health Organization: Perinatal mortality: a listing of available information, Maternal Health and Safe Motherhood Programme, WHO, Geneva (1996).

Kaynak Göster